intradermal injection ghk cu clinical trial GHK-Cu Peptide Before and After: What Changes Can You Expect? Microinfusion Serum Molecules: 2026 Evidence-Based

Researchers have administered doses hundreds of times higher than typical human protocols without observing toxic effects

It is a reasonable precaution in the absence of evidence either way

GHK-Cu is a small peptide composed of three amino acids - glycine, histidine, and lysine, bound to a copper ion

April 2026 Category 2 Update On April 15, 2026, the FDA confirmed removal of injectable GHK-Cu from Category 2 because the original nominations were withdrawn

How Dihexa Works: The Mechanism Behind the Magic The defining feature of Dihexa is its ability to enhance synaptogenesis , or the creation of new synaptic connections between neurons